Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bacil Pharma Ltd has informed the BSE that its trading window will remain closed for designated persons starting 1st April 2026, until 48 hours after the Board meeting concludes. The closure is in line with SEBI's Prohibition of Insider Trading Regulations, 2015. The Board meeting is being held to consider and approve the audited financial results for the quarter and financial year ended 31st March 2026. The exact date of the Board meeting will be communicated to the stock exchange separately. The intimation is signed by Director Ms. Chaitali Kalpataru Shah.
This is a routine compliance filing ahead of the Q4 and FY26 results announcement. Designated persons including directors and key employees cannot trade in the company's shares during this blackout period, which is standard practice before results are declared.